Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma
- PMID: 36280529
- DOI: 10.1016/j.urolonc.2022.09.020
Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma
Abstract
Introduction: A universally accepted model for preoperative surgical risk stratification in localized RCC patients undergoing nephrectomy is currently lacking. Both the evaluation of body composition and nutritional status has demonstrated prognostic value for patients with cancer. This study aims to investigate the potential associations between sarcopenia and hypoalbuminemia and survival outcomes in patients with localized kidney cancer treated with partial or radical nephrectomy.
Materials and methods: We retrospectively analyzed 473 patients with localized RCC managed with radical and partial nephrectomy. Skeletal muscle index (SMI) was measured from preoperative CT and MRI. Sarcopenic criteria were created using BMI- and sex-stratified thresholds. Relationships between sarcopenia and hypoalbuminemia (Albumin <3.5 g/dL) with overall (OS), recurrence-free (RFS), and cancer-specific survival (CSS) were determined using multivariable and Kaplan-Meier analysis.
Results: Of the 473 patients, 42.5% were sarcopenic and 24.5% had hypoalbuminemia. Sarcopenia was significantly associated with shorter OS (HR=1.51, 95% CI 1.07-2.13), however, was nonsignificant in the RFS (HR = 1.33, 95% CI 0.88-2.03) and CSS (HR=1.66, 95% CI 0.96-2.87) models. Hypoalbuminemia predicted shorter OS (HR=1.76, 95% CI 1.22-2.55), RFS (HR=1.86, 95% CI 1.19-2.89), and CSS (HR=1.82, 95% CI 1.03-3.22). Patients were then stratified into low, medium, and high-risk groups based on the severity of sarcopenia and hypoalbuminemia. Risk groups demonstrated an increasing association with shorter OS (all p<0.05). Reduced RFS was observed in the medium risk-hypoalbuminemia (HR=2.18, 95% CI 1.16-4.09) and high-risk groups (HR=2.42, 95% CI 1.34-4.39). Shorter CSS was observed in the medium risk-hypoalbuminemia (HR=2.31, 95% CI 1.00-5.30) and high-risk groups (HR=2.98, 95% CI 1.34-6.61).
Conclusion: Localized RCC patients with combined preoperative sarcopenia and hypoalbuminemia displayed a two to a three-fold reduction in OS, RFS, and CSS after nephrectomy. These data have implications for guiding prognostication and treatment election in localized RCC patients undergoing extirpative surgery.
Keywords: Albumin; Body composition; Nephrectomy; Nutrition; Renal cell carcinoma; Sarcopenia.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors have no conflicts of interest to disclose except for the following. Mehmet Asim Bilen has acted as a paid consultant and/or as a member of the advisory boards of Calithera Biosciences, Exelixis, Bayer, Bristol-Myers Squibb, Eisai, Pfizer, AstraZeneca, Janssen, Genomic Health, Nektar, and Sanofi and has received grants for his institution from Xencor, Bayer, Bristol-Myers Squibb, Genetech/Roche, Seattle Genetics, Incyte, Nektar, AstraZeneca, Tricon Pharmaceuticals, Genome & Company, AAA, Peleton Therapeutics, and Pfizer for work performed outside the current study.
Similar articles
-
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.Cancer. 2021 Jun 15;127(12):1974-1983. doi: 10.1002/cncr.33462. Epub 2021 Mar 24. Cancer. 2021. PMID: 33760232
-
Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.Clin Genitourin Cancer. 2023 Aug;21(4):475-482.e4. doi: 10.1016/j.clgc.2023.04.005. Epub 2023 Apr 19. Clin Genitourin Cancer. 2023. PMID: 37210313
-
Association Between Sarcopenia and Survival of Patients with Organ-Confined Renal Cell Carcinoma after Radical Nephrectomy.Ann Surg Oncol. 2022 Apr;29(4):2473-2479. doi: 10.1245/s10434-021-10881-7. Epub 2021 Oct 9. Ann Surg Oncol. 2022. PMID: 34625877
-
The role of sarcopenia in treatment-related outcomes in patients with renal cell carcinoma: A systematic review and meta-analysis.Medicine (Baltimore). 2022 Oct 28;101(43):e31332. doi: 10.1097/MD.0000000000031332. Medicine (Baltimore). 2022. PMID: 36316941 Free PMC article.
-
The prognostic value of the Controlling Nutritional Status score on patients undergoing nephrectomy for upper tract urothelial carcinoma or renal cell carcinoma: a systematic review and meta-analysis.Br J Nutr. 2022 Jul 28;128(2):217-224. doi: 10.1017/S0007114521002889. Epub 2021 Aug 2. Br J Nutr. 2022. PMID: 34338171
Cited by
-
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.Oncologist. 2023 Dec 11;28(12):e1219-e1229. doi: 10.1093/oncolo/oyad218. Oncologist. 2023. PMID: 37540787 Free PMC article.
-
Skeletal muscle and visceral adipose radiodensities are pre-surgical, non-invasive markers of aggressive kidney cancer.J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):726-734. doi: 10.1002/jcsm.13429. Epub 2024 Jan 24. J Cachexia Sarcopenia Muscle. 2024. PMID: 38263932 Free PMC article.
-
Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma.Biomedicines. 2023 Jun 1;11(6):1604. doi: 10.3390/biomedicines11061604. Biomedicines. 2023. PMID: 37371699 Free PMC article.
-
The impact of sarcopenia on the efficacy of posterior surgical treatment for degenerative lumbar scoliosis.BMC Surg. 2025 Aug 14;25(1):372. doi: 10.1186/s12893-025-03075-5. BMC Surg. 2025. PMID: 40813705 Free PMC article.
-
Advances in sarcopenia and urologic disorders.Front Nutr. 2024 Nov 6;11:1475977. doi: 10.3389/fnut.2024.1475977. eCollection 2024. Front Nutr. 2024. PMID: 39568720 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical